ombitasvir/paritaprevir/ritonavir & dasabuvir (DSC) will improve the degree or outcome of ergotamine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Acute ergot toxicity characterized by vasospasm and tissue ischemia has actually been connected with coadministration